In addition, we assessed whether METTL1 is a potential independent prognostic risk factor in gliomas by using a nomogram model. The purpose of this study was to explore the expression of METTL1 in glioma, its effect on the prognosis of patients, and to elucidate the potential molecular mechanism. The gene discussed is METTL1; the disease is central nervous system cancer.